Biodiversity accord will see tighter controls on use of genetic resources
This article was originally published in Scrip
Weary delegates to the COP10 (10th meeting of the Conference of the Parties) meeting on biological diversity in Japan hammered out a last-minute final agreement at the weekend on a new international protocol that it is hoped will put an end to "biopiracy".
You may also be interested in...
A busy stretch of deal-making across Asia all includes transactions involving Innovent, Alector, Ono, Numab, Alphamab, 3DMed, Healios, Athersys, Laekna, Novartis, Asahi Kasei, SBI Biotech, Glenmark, Hindustan Unilever, Hanlim, Alteogen, Ildong, Evotec, AJU Pharm, Ribomec, Tyligand, Context
New potential topical therapy in dermatitis space set to move towards Japan approval submission based on positive new results.
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.